At NYU Grossman School of Medicine, our commitment to innovation has led us to bold new ways of bridging the gap between basic science research, medical education, and quality of patient care. With ...

The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...